BMJ

订阅

MedSci主页 / 所有栏目 / BMJ

BMJ：溃疡创面出现营养不良性钙化

2016-03-11 MedSci MedSci原创

溃疡营养不良性钙化慢性静脉高血压
关注

女性患者，84岁，双侧腿部存在慢性溃疡，溃疡基底和皮下组织有大量的深棕色，骨性的，硬的钙化物沉积（如下图箭头所示）。

女性患者，84岁，双侧腿部存在慢性溃疡，溃疡基底和皮下组织有大量的深棕色，骨性的，硬的钙化物沉积（如下图箭头所示）。



下肢X线显示病损处出现广泛的网状钙化。血清钙、磷的水平均正常。

营养不良性钙化是慢性静脉高血压的一个常见并发症。其准确的发病率很难评估，据报道约为10-40%。由于疼痛性的不愈合的溃疡的存在，此疾病经常会被漏诊，保守治疗无效。不能确诊时可借助放射检查。

手术切除联合网状皮肤移植已用于此病的治疗，治疗的效果各异。

原始出处：

Amina Khalid, Alyson Bryden.Dystrophic calcification in leg ulcers. BMJ 2016; 352 doi: http://dx.doi.org/10.1136/bmj.i1325 (Published 10 March 2016)Cite this as: BMJ 2016;352:i1325.

版权声明：
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言
评论区 (10)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1847937, encodeId=a9d4184e9376f, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Thu Dec 08 04:28:00 CST 2016, time=2016-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1631979, encodeId=974416319e9ad, content=<a href='/topic/show?id=b88a321e6b2' target=_blank style='color:#2F92EE;'>#创面#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32176, encryptionId=b88a321e6b2, topicName=创面)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6fda21837820, createdName=qindq, createdTime=Wed Nov 16 12:28:00 CST 2016, time=2016-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=72081, encodeId=3e4ce208110, content=谢谢，值得学习。, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73801651090, createdName=1ddc978cm67(暂无匿称), createdTime=Mon Mar 21 07:13:00 CST 2016, time=2016-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=69392, encodeId=145a6939207, content=未来的方向，不知道是否会进一步发展, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160314/IMG56E64D2A545669487.jpg, createdBy=4ff71699844, createdName=古天乐, createdTime=Mon Mar 14 13:41:00 CST 2016, time=2016-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=69393, encodeId=28f569393bb, content=未来的方向，不知道是否会进一步发展, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160314/IMG56E64D2A545669487.jpg, createdBy=4ff71699844, createdName=古天乐, createdTime=Mon Mar 14 13:41:00 CST 2016, time=2016-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=69394, encodeId=e08169394cb, content=未来的方向，不知道是否会进一步发展, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160314/IMG56E64D2A545669487.jpg, createdBy=4ff71699844, createdName=古天乐, createdTime=Mon Mar 14 13:41:00 CST 2016, time=2016-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=69395, encodeId=ce98693959c, content=未来的方向，不知道是否会进一步发展, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160314/IMG56E64D2A545669487.jpg, createdBy=4ff71699844, createdName=古天乐, createdTime=Mon Mar 14 13:41:00 CST 2016, time=2016-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=69389, encodeId=904a69389ab, content=未来的方向，不知道是否会进一步发展, beContent=null, objectType=article, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160314/IMG56E64D2A545669487.jpg, createdBy=4ff71699844, createdName=古天乐, createdTime=Mon Mar 14 13:40:00 CST 2016, time=2016-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=69390, encodeId=ed0e69390d7, content=表示在科室看过一个, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160314/IMG56E64D2A545669487.jpg, createdBy=4ff71699844, createdName=古天乐, createdTime=Mon Mar 14 13:40:00 CST 2016, time=2016-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=69391, encodeId=557269391e1, content=未来的方向，不知道是否会进一步发展, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160314/IMG56E64D2A545669487.jpg, createdBy=4ff71699844, createdName=古天乐, createdTime=Mon Mar 14 13:40:00 CST 2016, time=2016-03-14, status=1, ipAttribution=)]
    2016-12-08 gaoxiaoe

    #BMJ#

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1847937, encodeId=a9d4184e9376f, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Thu Dec 08 04:28:00 CST 2016, time=2016-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1631979, encodeId=974416319e9ad, content=<a href='/topic/show?id=b88a321e6b2' target=_blank style='color:#2F92EE;'>#创面#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32176, encryptionId=b88a321e6b2, topicName=创面)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6fda21837820, createdName=qindq, createdTime=Wed Nov 16 12:28:00 CST 2016, time=2016-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=72081, encodeId=3e4ce208110, content=谢谢，值得学习。, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73801651090, createdName=1ddc978cm67(暂无匿称), createdTime=Mon Mar 21 07:13:00 CST 2016, time=2016-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=69392, encodeId=145a6939207, content=未来的方向，不知道是否会进一步发展, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160314/IMG56E64D2A545669487.jpg, createdBy=4ff71699844, createdName=古天乐, createdTime=Mon Mar 14 13:41:00 CST 2016, time=2016-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=69393, encodeId=28f569393bb, content=未来的方向，不知道是否会进一步发展, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160314/IMG56E64D2A545669487.jpg, createdBy=4ff71699844, createdName=古天乐, createdTime=Mon Mar 14 13:41:00 CST 2016, time=2016-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=69394, encodeId=e08169394cb, content=未来的方向，不知道是否会进一步发展, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160314/IMG56E64D2A545669487.jpg, createdBy=4ff71699844, createdName=古天乐, createdTime=Mon Mar 14 13:41:00 CST 2016, time=2016-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=69395, encodeId=ce98693959c, content=未来的方向，不知道是否会进一步发展, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160314/IMG56E64D2A545669487.jpg, createdBy=4ff71699844, createdName=古天乐, createdTime=Mon Mar 14 13:41:00 CST 2016, time=2016-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=69389, encodeId=904a69389ab, content=未来的方向，不知道是否会进一步发展, beContent=null, objectType=article, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160314/IMG56E64D2A545669487.jpg, createdBy=4ff71699844, createdName=古天乐, createdTime=Mon Mar 14 13:40:00 CST 2016, time=2016-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=69390, encodeId=ed0e69390d7, content=表示在科室看过一个, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160314/IMG56E64D2A545669487.jpg, createdBy=4ff71699844, createdName=古天乐, createdTime=Mon Mar 14 13:40:00 CST 2016, time=2016-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=69391, encodeId=557269391e1, content=未来的方向，不知道是否会进一步发展, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160314/IMG56E64D2A545669487.jpg, createdBy=4ff71699844, createdName=古天乐, createdTime=Mon Mar 14 13:40:00 CST 2016, time=2016-03-14, status=1, ipAttribution=)]
    2016-11-16 qindq

    #创面#

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1847937, encodeId=a9d4184e9376f, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Thu Dec 08 04:28:00 CST 2016, time=2016-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1631979, encodeId=974416319e9ad, content=<a href='/topic/show?id=b88a321e6b2' target=_blank style='color:#2F92EE;'>#创面#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32176, encryptionId=b88a321e6b2, topicName=创面)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6fda21837820, createdName=qindq, createdTime=Wed Nov 16 12:28:00 CST 2016, time=2016-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=72081, encodeId=3e4ce208110, content=谢谢，值得学习。, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73801651090, createdName=1ddc978cm67(暂无匿称), createdTime=Mon Mar 21 07:13:00 CST 2016, time=2016-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=69392, encodeId=145a6939207, content=未来的方向，不知道是否会进一步发展, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160314/IMG56E64D2A545669487.jpg, createdBy=4ff71699844, createdName=古天乐, createdTime=Mon Mar 14 13:41:00 CST 2016, time=2016-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=69393, encodeId=28f569393bb, content=未来的方向，不知道是否会进一步发展, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160314/IMG56E64D2A545669487.jpg, createdBy=4ff71699844, createdName=古天乐, createdTime=Mon Mar 14 13:41:00 CST 2016, time=2016-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=69394, encodeId=e08169394cb, content=未来的方向，不知道是否会进一步发展, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160314/IMG56E64D2A545669487.jpg, createdBy=4ff71699844, createdName=古天乐, createdTime=Mon Mar 14 13:41:00 CST 2016, time=2016-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=69395, encodeId=ce98693959c, content=未来的方向，不知道是否会进一步发展, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160314/IMG56E64D2A545669487.jpg, createdBy=4ff71699844, createdName=古天乐, createdTime=Mon Mar 14 13:41:00 CST 2016, time=2016-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=69389, encodeId=904a69389ab, content=未来的方向，不知道是否会进一步发展, beContent=null, objectType=article, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160314/IMG56E64D2A545669487.jpg, createdBy=4ff71699844, createdName=古天乐, createdTime=Mon Mar 14 13:40:00 CST 2016, time=2016-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=69390, encodeId=ed0e69390d7, content=表示在科室看过一个, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160314/IMG56E64D2A545669487.jpg, createdBy=4ff71699844, createdName=古天乐, createdTime=Mon Mar 14 13:40:00 CST 2016, time=2016-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=69391, encodeId=557269391e1, content=未来的方向，不知道是否会进一步发展, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160314/IMG56E64D2A545669487.jpg, createdBy=4ff71699844, createdName=古天乐, createdTime=Mon Mar 14 13:40:00 CST 2016, time=2016-03-14, status=1, ipAttribution=)]
    2016-03-21 1ddc978cm67(暂无匿称)

    谢谢，值得学习。

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1847937, encodeId=a9d4184e9376f, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Thu Dec 08 04:28:00 CST 2016, time=2016-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1631979, encodeId=974416319e9ad, content=<a href='/topic/show?id=b88a321e6b2' target=_blank style='color:#2F92EE;'>#创面#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32176, encryptionId=b88a321e6b2, topicName=创面)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6fda21837820, createdName=qindq, createdTime=Wed Nov 16 12:28:00 CST 2016, time=2016-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=72081, encodeId=3e4ce208110, content=谢谢，值得学习。, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73801651090, createdName=1ddc978cm67(暂无匿称), createdTime=Mon Mar 21 07:13:00 CST 2016, time=2016-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=69392, encodeId=145a6939207, content=未来的方向，不知道是否会进一步发展, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160314/IMG56E64D2A545669487.jpg, createdBy=4ff71699844, createdName=古天乐, createdTime=Mon Mar 14 13:41:00 CST 2016, time=2016-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=69393, encodeId=28f569393bb, content=未来的方向，不知道是否会进一步发展, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160314/IMG56E64D2A545669487.jpg, createdBy=4ff71699844, createdName=古天乐, createdTime=Mon Mar 14 13:41:00 CST 2016, time=2016-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=69394, encodeId=e08169394cb, content=未来的方向，不知道是否会进一步发展, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160314/IMG56E64D2A545669487.jpg, createdBy=4ff71699844, createdName=古天乐, createdTime=Mon Mar 14 13:41:00 CST 2016, time=2016-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=69395, encodeId=ce98693959c, content=未来的方向，不知道是否会进一步发展, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160314/IMG56E64D2A545669487.jpg, createdBy=4ff71699844, createdName=古天乐, createdTime=Mon Mar 14 13:41:00 CST 2016, time=2016-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=69389, encodeId=904a69389ab, content=未来的方向，不知道是否会进一步发展, beContent=null, objectType=article, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160314/IMG56E64D2A545669487.jpg, createdBy=4ff71699844, createdName=古天乐, createdTime=Mon Mar 14 13:40:00 CST 2016, time=2016-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=69390, encodeId=ed0e69390d7, content=表示在科室看过一个, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160314/IMG56E64D2A545669487.jpg, createdBy=4ff71699844, createdName=古天乐, createdTime=Mon Mar 14 13:40:00 CST 2016, time=2016-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=69391, encodeId=557269391e1, content=未来的方向，不知道是否会进一步发展, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160314/IMG56E64D2A545669487.jpg, createdBy=4ff71699844, createdName=古天乐, createdTime=Mon Mar 14 13:40:00 CST 2016, time=2016-03-14, status=1, ipAttribution=)]
    2016-03-14 古天乐

    未来的方向，不知道是否会进一步发展

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1847937, encodeId=a9d4184e9376f, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Thu Dec 08 04:28:00 CST 2016, time=2016-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1631979, encodeId=974416319e9ad, content=<a href='/topic/show?id=b88a321e6b2' target=_blank style='color:#2F92EE;'>#创面#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32176, encryptionId=b88a321e6b2, topicName=创面)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6fda21837820, createdName=qindq, createdTime=Wed Nov 16 12:28:00 CST 2016, time=2016-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=72081, encodeId=3e4ce208110, content=谢谢，值得学习。, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73801651090, createdName=1ddc978cm67(暂无匿称), createdTime=Mon Mar 21 07:13:00 CST 2016, time=2016-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=69392, encodeId=145a6939207, content=未来的方向，不知道是否会进一步发展, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160314/IMG56E64D2A545669487.jpg, createdBy=4ff71699844, createdName=古天乐, createdTime=Mon Mar 14 13:41:00 CST 2016, time=2016-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=69393, encodeId=28f569393bb, content=未来的方向，不知道是否会进一步发展, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160314/IMG56E64D2A545669487.jpg, createdBy=4ff71699844, createdName=古天乐, createdTime=Mon Mar 14 13:41:00 CST 2016, time=2016-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=69394, encodeId=e08169394cb, content=未来的方向，不知道是否会进一步发展, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160314/IMG56E64D2A545669487.jpg, createdBy=4ff71699844, createdName=古天乐, createdTime=Mon Mar 14 13:41:00 CST 2016, time=2016-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=69395, encodeId=ce98693959c, content=未来的方向，不知道是否会进一步发展, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160314/IMG56E64D2A545669487.jpg, createdBy=4ff71699844, createdName=古天乐, createdTime=Mon Mar 14 13:41:00 CST 2016, time=2016-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=69389, encodeId=904a69389ab, content=未来的方向，不知道是否会进一步发展, beContent=null, objectType=article, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160314/IMG56E64D2A545669487.jpg, createdBy=4ff71699844, createdName=古天乐, createdTime=Mon Mar 14 13:40:00 CST 2016, time=2016-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=69390, encodeId=ed0e69390d7, content=表示在科室看过一个, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160314/IMG56E64D2A545669487.jpg, createdBy=4ff71699844, createdName=古天乐, createdTime=Mon Mar 14 13:40:00 CST 2016, time=2016-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=69391, encodeId=557269391e1, content=未来的方向，不知道是否会进一步发展, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160314/IMG56E64D2A545669487.jpg, createdBy=4ff71699844, createdName=古天乐, createdTime=Mon Mar 14 13:40:00 CST 2016, time=2016-03-14, status=1, ipAttribution=)]
    2016-03-14 古天乐

    未来的方向，不知道是否会进一步发展

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1847937, encodeId=a9d4184e9376f, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Thu Dec 08 04:28:00 CST 2016, time=2016-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1631979, encodeId=974416319e9ad, content=<a href='/topic/show?id=b88a321e6b2' target=_blank style='color:#2F92EE;'>#创面#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32176, encryptionId=b88a321e6b2, topicName=创面)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6fda21837820, createdName=qindq, createdTime=Wed Nov 16 12:28:00 CST 2016, time=2016-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=72081, encodeId=3e4ce208110, content=谢谢，值得学习。, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73801651090, createdName=1ddc978cm67(暂无匿称), createdTime=Mon Mar 21 07:13:00 CST 2016, time=2016-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=69392, encodeId=145a6939207, content=未来的方向，不知道是否会进一步发展, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160314/IMG56E64D2A545669487.jpg, createdBy=4ff71699844, createdName=古天乐, createdTime=Mon Mar 14 13:41:00 CST 2016, time=2016-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=69393, encodeId=28f569393bb, content=未来的方向，不知道是否会进一步发展, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160314/IMG56E64D2A545669487.jpg, createdBy=4ff71699844, createdName=古天乐, createdTime=Mon Mar 14 13:41:00 CST 2016, time=2016-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=69394, encodeId=e08169394cb, content=未来的方向，不知道是否会进一步发展, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160314/IMG56E64D2A545669487.jpg, createdBy=4ff71699844, createdName=古天乐, createdTime=Mon Mar 14 13:41:00 CST 2016, time=2016-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=69395, encodeId=ce98693959c, content=未来的方向，不知道是否会进一步发展, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160314/IMG56E64D2A545669487.jpg, createdBy=4ff71699844, createdName=古天乐, createdTime=Mon Mar 14 13:41:00 CST 2016, time=2016-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=69389, encodeId=904a69389ab, content=未来的方向，不知道是否会进一步发展, beContent=null, objectType=article, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160314/IMG56E64D2A545669487.jpg, createdBy=4ff71699844, createdName=古天乐, createdTime=Mon Mar 14 13:40:00 CST 2016, time=2016-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=69390, encodeId=ed0e69390d7, content=表示在科室看过一个, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160314/IMG56E64D2A545669487.jpg, createdBy=4ff71699844, createdName=古天乐, createdTime=Mon Mar 14 13:40:00 CST 2016, time=2016-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=69391, encodeId=557269391e1, content=未来的方向，不知道是否会进一步发展, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160314/IMG56E64D2A545669487.jpg, createdBy=4ff71699844, createdName=古天乐, createdTime=Mon Mar 14 13:40:00 CST 2016, time=2016-03-14, status=1, ipAttribution=)]
    2016-03-14 古天乐

    未来的方向，不知道是否会进一步发展

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1847937, encodeId=a9d4184e9376f, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Thu Dec 08 04:28:00 CST 2016, time=2016-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1631979, encodeId=974416319e9ad, content=<a href='/topic/show?id=b88a321e6b2' target=_blank style='color:#2F92EE;'>#创面#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32176, encryptionId=b88a321e6b2, topicName=创面)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6fda21837820, createdName=qindq, createdTime=Wed Nov 16 12:28:00 CST 2016, time=2016-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=72081, encodeId=3e4ce208110, content=谢谢，值得学习。, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73801651090, createdName=1ddc978cm67(暂无匿称), createdTime=Mon Mar 21 07:13:00 CST 2016, time=2016-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=69392, encodeId=145a6939207, content=未来的方向，不知道是否会进一步发展, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160314/IMG56E64D2A545669487.jpg, createdBy=4ff71699844, createdName=古天乐, createdTime=Mon Mar 14 13:41:00 CST 2016, time=2016-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=69393, encodeId=28f569393bb, content=未来的方向，不知道是否会进一步发展, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160314/IMG56E64D2A545669487.jpg, createdBy=4ff71699844, createdName=古天乐, createdTime=Mon Mar 14 13:41:00 CST 2016, time=2016-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=69394, encodeId=e08169394cb, content=未来的方向，不知道是否会进一步发展, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160314/IMG56E64D2A545669487.jpg, createdBy=4ff71699844, createdName=古天乐, createdTime=Mon Mar 14 13:41:00 CST 2016, time=2016-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=69395, encodeId=ce98693959c, content=未来的方向，不知道是否会进一步发展, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160314/IMG56E64D2A545669487.jpg, createdBy=4ff71699844, createdName=古天乐, createdTime=Mon Mar 14 13:41:00 CST 2016, time=2016-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=69389, encodeId=904a69389ab, content=未来的方向，不知道是否会进一步发展, beContent=null, objectType=article, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160314/IMG56E64D2A545669487.jpg, createdBy=4ff71699844, createdName=古天乐, createdTime=Mon Mar 14 13:40:00 CST 2016, time=2016-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=69390, encodeId=ed0e69390d7, content=表示在科室看过一个, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160314/IMG56E64D2A545669487.jpg, createdBy=4ff71699844, createdName=古天乐, createdTime=Mon Mar 14 13:40:00 CST 2016, time=2016-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=69391, encodeId=557269391e1, content=未来的方向，不知道是否会进一步发展, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160314/IMG56E64D2A545669487.jpg, createdBy=4ff71699844, createdName=古天乐, createdTime=Mon Mar 14 13:40:00 CST 2016, time=2016-03-14, status=1, ipAttribution=)]
    2016-03-14 古天乐

    未来的方向，不知道是否会进一步发展

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1847937, encodeId=a9d4184e9376f, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Thu Dec 08 04:28:00 CST 2016, time=2016-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1631979, encodeId=974416319e9ad, content=<a href='/topic/show?id=b88a321e6b2' target=_blank style='color:#2F92EE;'>#创面#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32176, encryptionId=b88a321e6b2, topicName=创面)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6fda21837820, createdName=qindq, createdTime=Wed Nov 16 12:28:00 CST 2016, time=2016-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=72081, encodeId=3e4ce208110, content=谢谢，值得学习。, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73801651090, createdName=1ddc978cm67(暂无匿称), createdTime=Mon Mar 21 07:13:00 CST 2016, time=2016-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=69392, encodeId=145a6939207, content=未来的方向，不知道是否会进一步发展, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160314/IMG56E64D2A545669487.jpg, createdBy=4ff71699844, createdName=古天乐, createdTime=Mon Mar 14 13:41:00 CST 2016, time=2016-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=69393, encodeId=28f569393bb, content=未来的方向，不知道是否会进一步发展, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160314/IMG56E64D2A545669487.jpg, createdBy=4ff71699844, createdName=古天乐, createdTime=Mon Mar 14 13:41:00 CST 2016, time=2016-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=69394, encodeId=e08169394cb, content=未来的方向，不知道是否会进一步发展, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160314/IMG56E64D2A545669487.jpg, createdBy=4ff71699844, createdName=古天乐, createdTime=Mon Mar 14 13:41:00 CST 2016, time=2016-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=69395, encodeId=ce98693959c, content=未来的方向，不知道是否会进一步发展, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160314/IMG56E64D2A545669487.jpg, createdBy=4ff71699844, createdName=古天乐, createdTime=Mon Mar 14 13:41:00 CST 2016, time=2016-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=69389, encodeId=904a69389ab, content=未来的方向，不知道是否会进一步发展, beContent=null, objectType=article, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160314/IMG56E64D2A545669487.jpg, createdBy=4ff71699844, createdName=古天乐, createdTime=Mon Mar 14 13:40:00 CST 2016, time=2016-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=69390, encodeId=ed0e69390d7, content=表示在科室看过一个, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160314/IMG56E64D2A545669487.jpg, createdBy=4ff71699844, createdName=古天乐, createdTime=Mon Mar 14 13:40:00 CST 2016, time=2016-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=69391, encodeId=557269391e1, content=未来的方向，不知道是否会进一步发展, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160314/IMG56E64D2A545669487.jpg, createdBy=4ff71699844, createdName=古天乐, createdTime=Mon Mar 14 13:40:00 CST 2016, time=2016-03-14, status=1, ipAttribution=)]
    2016-03-14 古天乐

    未来的方向，不知道是否会进一步发展

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=1847937, encodeId=a9d4184e9376f, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Thu Dec 08 04:28:00 CST 2016, time=2016-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1631979, encodeId=974416319e9ad, content=<a href='/topic/show?id=b88a321e6b2' target=_blank style='color:#2F92EE;'>#创面#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32176, encryptionId=b88a321e6b2, topicName=创面)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6fda21837820, createdName=qindq, createdTime=Wed Nov 16 12:28:00 CST 2016, time=2016-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=72081, encodeId=3e4ce208110, content=谢谢，值得学习。, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73801651090, createdName=1ddc978cm67(暂无匿称), createdTime=Mon Mar 21 07:13:00 CST 2016, time=2016-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=69392, encodeId=145a6939207, content=未来的方向，不知道是否会进一步发展, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160314/IMG56E64D2A545669487.jpg, createdBy=4ff71699844, createdName=古天乐, createdTime=Mon Mar 14 13:41:00 CST 2016, time=2016-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=69393, encodeId=28f569393bb, content=未来的方向，不知道是否会进一步发展, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160314/IMG56E64D2A545669487.jpg, createdBy=4ff71699844, createdName=古天乐, createdTime=Mon Mar 14 13:41:00 CST 2016, time=2016-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=69394, encodeId=e08169394cb, content=未来的方向，不知道是否会进一步发展, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160314/IMG56E64D2A545669487.jpg, createdBy=4ff71699844, createdName=古天乐, createdTime=Mon Mar 14 13:41:00 CST 2016, time=2016-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=69395, encodeId=ce98693959c, content=未来的方向，不知道是否会进一步发展, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160314/IMG56E64D2A545669487.jpg, createdBy=4ff71699844, createdName=古天乐, createdTime=Mon Mar 14 13:41:00 CST 2016, time=2016-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=69389, encodeId=904a69389ab, content=未来的方向，不知道是否会进一步发展, beContent=null, objectType=article, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160314/IMG56E64D2A545669487.jpg, createdBy=4ff71699844, createdName=古天乐, createdTime=Mon Mar 14 13:40:00 CST 2016, time=2016-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=69390, encodeId=ed0e69390d7, content=表示在科室看过一个, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160314/IMG56E64D2A545669487.jpg, createdBy=4ff71699844, createdName=古天乐, createdTime=Mon Mar 14 13:40:00 CST 2016, time=2016-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=69391, encodeId=557269391e1, content=未来的方向，不知道是否会进一步发展, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160314/IMG56E64D2A545669487.jpg, createdBy=4ff71699844, createdName=古天乐, createdTime=Mon Mar 14 13:40:00 CST 2016, time=2016-03-14, status=1, ipAttribution=)]
    2016-03-14 古天乐

    表示在科室看过一个

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=1847937, encodeId=a9d4184e9376f, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Thu Dec 08 04:28:00 CST 2016, time=2016-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1631979, encodeId=974416319e9ad, content=<a href='/topic/show?id=b88a321e6b2' target=_blank style='color:#2F92EE;'>#创面#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32176, encryptionId=b88a321e6b2, topicName=创面)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6fda21837820, createdName=qindq, createdTime=Wed Nov 16 12:28:00 CST 2016, time=2016-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=72081, encodeId=3e4ce208110, content=谢谢，值得学习。, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73801651090, createdName=1ddc978cm67(暂无匿称), createdTime=Mon Mar 21 07:13:00 CST 2016, time=2016-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=69392, encodeId=145a6939207, content=未来的方向，不知道是否会进一步发展, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160314/IMG56E64D2A545669487.jpg, createdBy=4ff71699844, createdName=古天乐, createdTime=Mon Mar 14 13:41:00 CST 2016, time=2016-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=69393, encodeId=28f569393bb, content=未来的方向，不知道是否会进一步发展, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160314/IMG56E64D2A545669487.jpg, createdBy=4ff71699844, createdName=古天乐, createdTime=Mon Mar 14 13:41:00 CST 2016, time=2016-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=69394, encodeId=e08169394cb, content=未来的方向，不知道是否会进一步发展, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160314/IMG56E64D2A545669487.jpg, createdBy=4ff71699844, createdName=古天乐, createdTime=Mon Mar 14 13:41:00 CST 2016, time=2016-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=69395, encodeId=ce98693959c, content=未来的方向，不知道是否会进一步发展, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160314/IMG56E64D2A545669487.jpg, createdBy=4ff71699844, createdName=古天乐, createdTime=Mon Mar 14 13:41:00 CST 2016, time=2016-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=69389, encodeId=904a69389ab, content=未来的方向，不知道是否会进一步发展, beContent=null, objectType=article, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160314/IMG56E64D2A545669487.jpg, createdBy=4ff71699844, createdName=古天乐, createdTime=Mon Mar 14 13:40:00 CST 2016, time=2016-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=69390, encodeId=ed0e69390d7, content=表示在科室看过一个, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160314/IMG56E64D2A545669487.jpg, createdBy=4ff71699844, createdName=古天乐, createdTime=Mon Mar 14 13:40:00 CST 2016, time=2016-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=69391, encodeId=557269391e1, content=未来的方向，不知道是否会进一步发展, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160314/IMG56E64D2A545669487.jpg, createdBy=4ff71699844, createdName=古天乐, createdTime=Mon Mar 14 13:40:00 CST 2016, time=2016-03-14, status=1, ipAttribution=)]
    2016-03-14 古天乐

    未来的方向，不知道是否会进一步发展

    0

以上为热门评论，梅斯医学App还有更多内容

相关资讯

Gastroenterology：甲氨蝶呤治疗溃疡性结肠炎

对克罗恩病的患者而言，肠外使用甲氨蝶呤是一种有效的治疗方式，但对于溃疡性结肠炎（UC）患者，该种治疗方式并没有得到合适的评估。因此研究者进行了一项随机对照试验，探究甲氨蝶呤对激素依赖性UC患者的有效性。该双盲安慰剂对照试验纳入了111名激素依赖性UC患者，在纳入研究时均予以10-40毫克/天的强的松，按1：1随机分为试验组（肌肉或皮下注射甲氨蝶呤 25毫克/周）和对照组，给药24周。以16周时不依

NEJM：一例以头痛、头皮溃疡恶化3个月的病例报道

男性，74岁，因出现头痛、头颅跛行，并伴有头皮溃疡恶化3个月而来院就诊。据该男子主诉，他没有出现视力丧失或风湿性肌肉疼痛等症状。

FDA：Omnigraft可用于治疗糖尿病足

FDA批准Integra Omnigraft Dermal Regeneration Matrix (Omnigraft)可用于治疗糖尿病足溃疡。该物由硅树脂、牛胶原蛋白和鲨鱼软骨组成，将其放置于溃疡之处，便可促使新皮肤和组织的再生，并能促进伤口的愈合。据估计美国约有2900万人被诊断出患有糖尿病,CDC估计,其中约25%的糖尿病患者将出现足部溃疡。由于慢性糖尿病导致的足部组织溃疡与骨感染导致每年

Gastroenterology：通过粪便中钙卫蛋白对溃疡性结肠炎患者结局进行预测

研究者对一项研究的数据进行了析因分析，该研究探究了托法替尼治疗的中到重度溃疡性结肠炎患者，其粪便中钙卫蛋白(FCP)浓度和临床和内镜结局的关系。该双盲安慰剂对照的2期试验纳入了194名患者，随机分为试验组（托法替尼 0.5、3、10, or 15 mg，每天两次）和对照组。在第8周使用梅奥评分系统评估临床和内镜结局。使用ROC评估FCP浓度和临床与内镜结局的关系，明确与患者结局相关的FCP阈值浓度

彻底改变人类健康的5份研究报告

在医院的候诊大厅里，你不可能找到类似于《柳叶刀》、《美国医学会杂志》这样的期刊，但是这些杂志对你的健康却产生了实实在在的影响。 在这些杂志里，科学家们发表研究结果，综述文献，向世人介绍：疾病是如何发生的？哪些药物可以拯救生命？哪种手术方法是最好的？ 第一个科学杂志《哲学汇刊》（Philosophical Transactions）  发行于350年前。现在仍在刊印，拥有数

NEJM：罕见原发性伴继发性梅毒感染-案例报道

男性，68岁，无既往病史，今因嘴唇上部出现侵蚀性溃疡伴剧烈疼痛而到院就诊（如图A所示）。据该男子主诉嘴唇出现病变已有6周余。体格检查可见，该男子的手及脚（包括手掌和脚掌）可见大范围边界清楚的红斑、鳞屑斑（如图B、C、D所示）。除此以外，未见其他异常症状。实验室检查结果显示梅毒螺旋体颗粒凝集试验阳性（滴度为1:2560；正常值＜1:80）、性病研究室试验结果呈阳性（滴度1:8；正常值＜1:2）。人类